New research will target earliest stages of bone marrow cancer
A new programme, funded by Cancer Research UK and led by BHP founder-member the University of Birmingham, has set out to attempt to eradicate a major and incurable bone marrow cancer.
An interdi…
Improving screening in underrepresented groups for genetic condition with heart complications
Researchers from across BHP are collaborating with community groups and Amicus Therapeutics to improve screening and diagnosis of Fabry disease, a rare and inherited condition where complications a…
University of Birmingham awarded £7m NIHR funding to provide strategic leadership for its Research Support Service
The NIHR has selected BHP founder-member the University of Birmingham to run the National Collaborative for its Research Support Service (RSS) from 1 February 2024.
The RSS was launched on 1 Oc…
LIBERATE heart attack trial treats first patient
The first patient has been treated in the LIBERATE clinical study to evaluate glenzocimab efficacy in myocardial infarction, which involves BHP members the University of Birmingham and University H…
Aston University launches SPARK The Midlands to support health tech innovation
Aston University, a member of BHP, has launched SPARK The Midlands, a network which aims to bridge the gap between medical research discoveries of novel therapeutics, medical devices and diagn…
New treatment combination may improve outcomes for children with rare cancers
Children who develop neuroblastomas, a rare form of cancer which develops in nerve cells, may benefit from receiving certain anti-tumour drugs as well as chemotherapy, a new trial has found.
The…